AURKB, HDAC2, PLK1, CENPA, CHEK1, CHEK2, RB1, and MDM2 genes, which were included in at least three pathways, are expected to play an important role in the promotion and maintenance of CCDC170-subtype breast cancer. This evidence concerns the gene MDM2 and breast carcinoma.